Skip to main content
Summaries with Critical Appraisal:
- Off-Label Use of Intravenous Immunoglobulin for Non-Neurological Paraneoplastic Disorders: A Review of Clinical Effectiveness (Summary with Critical Appraisal, April 2018)
- Off-Label Use of Intravenous Immunoglobulin for Solid Organ Transplant Rejection: A Review of Clinical Effectiveness (Summary with Critical Appraisal, April 2018)
- Off-Label Use of Intravenous Immunoglobulin for Recurrent Spontaneous Abortion: A Review of Clinical Effectiveness (Summary with Critical Appraisal, May 2018)
- Off-Label Use of Intravenous Immunoglobulin for Dermatological Conditions: A Review of Clinical Effectiveness (Summary with Critical Appraisal, April 2018)
- Off-Label Use of Intravenous Immunoglobulin for Autoimmune or Inflammatory Conditions: A Review of Clinical Effectiveness (Summary with Critical Appraisal, April 2018)
- Off-Label Use of Intravenous Immunoglobulin for Hematological Conditions: A Review of Clinical Effectiveness (Summary with Critical Appraisal, March 2018)
- Off-Label Use of Intravenous Immunoglobulin for Neurological Conditions: A Review of Clinical Effectiveness (Summary with Critical Appraisal, March 2018)
- Off-Label Use of Intravenous Immunoglobulin: A Review of Clinical Effectiveness (Summary with Critical Appraisal, November 2017)
- Immunomodulatory Drugs and Intravenous Immunoglobulin (IVIg) for Patients with Chronic Demyelinating Polyneuropathy Who Are in Remission: A Review of Clinical and Cost-effectiveness and Guidelines (Summary with Critical Appraisal, March 2015)
- Management and Patient Safety of IVIG Administration: A Review of Clinical Practice Guidelines (Summary with Critical Appraisal, February 2011)
Summaries of Abstracts:
Heath Technology Assessments: